I agree. You are correct when you analyse what we have.
I don't think there is any chance of a really big number in a takeover, that scenario is in a perfect world with a perfect buyer and everything going to plan but I do hold some optimism the potential of 2591 will mean whoever puts a bid in will pay a bit more than expected. So, on balance, it would equal a Reata number, maybe slightly lower, maybe, slightly higher.
If a Reata number is 85AUD, who would not take between $60 and $100 before a phase 3 trial placebo-controlled trial? I expect a lower-end number to test Neuren's self-belief before the real negotiating starts.
The risk-reward for Neuren leads me to believe this zone of offer would be acceptable to them. If 2591 is that good, someone will offer a figure between these numbers after the FDA meeting and disclosure of the new indications.
I think this scenario would leave both seller and buyer content.
Gone by Xmas.
Just my thoughts.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-11132
-
-
- There are more pages in this discussion • 739 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.80 |
Change
0.035(0.25%) |
Mkt cap ! $1.758B |
Open | High | Low | Value | Volume |
$13.86 | $13.95 | $13.46 | $3.713M | 270.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 121 | $13.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.80 | 693 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 793 | 13.780 |
12 | 579 | 13.770 |
5 | 331 | 13.760 |
3 | 319 | 13.750 |
6 | 366 | 13.740 |
Price($) | Vol. | No. |
---|---|---|
13.800 | 537 | 17 |
13.810 | 634 | 9 |
13.820 | 310 | 3 |
13.830 | 373 | 4 |
13.840 | 575 | 4 |
Last trade - 15.04pm 16/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |